Gene · 59340
Papers1,168
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,168
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRPV4 promotes histamine receptor signaling in lymphatic endothelial cells. | Cell Calcium | 2026 | 42664800 | PubTator, text mining | PubMed |
| Virtual Screening, Synthesis and In Vitro Characterization of Histamine H4 Receptor Ligands Based on Pyrimidine Scaffolds. | Int J Mol Sci | 2026 | 42589546 | PubTator, text mining | PubMed |
| A subset of histamine H4 receptor antagonists prevents B lymphocyte proliferation induced by BCR/TLR9 engagement or EBV infection. | Antiviral Res | 2026 | 42140525 | PubTator, text mining | PubMed |
| Histamine H4 receptor in neuroinflammation: Dual roles in multiple sclerosis and Parkinson's disease. | Neurobiol Dis | 2026 | 41997459 | PubTator, text mining | PubMed |
| Quantitative deciphering of mammalian histamine receptors through mathematical genomics. | Biochem Biophys Res Commun | 2026 | 41946080 | PubTator, text mining | PubMed |
| A Potential Central Hub of Histamine in the Microbiota-Gut-Joint Axis in Rheumatoid Arthritis: Mechanisms and Translational Implications. | Int J Mol Sci | 2026 | 41828539 | PubTator, text mining | PubMed |
| Differential conservation analysis identifies residues defining constitutive internalization in beta-adrenergic receptors. | iScience | 2026 | 41797919 | PubTator, text mining | PubMed |
Computational approaches for the identification of potential HDAC2 inhibitors and histamine H3 receptor antagonists from Berberis vulgaris: a dual mechanistic approach for autism spectrum disorder treatment. | Open Life Sci | 2026 | 41737604 | PubTator, text mining | PubMed |
| Deciphering the air pollution-osteoarthritis relationship: insights from network toxicology, integrated machine learning, and molecular docking. | Environ Geochem Health | 2026 | 41718809 | PubTator, text mining | PubMed |
| Cystamine is a redox-dependent inverse agonist of the histamine H4 receptor. | Am J Physiol Cell Physiol | 2026 | 41481277 | PubTator, text mining | PubMed |
| Decoding ligand recognition and constitutive activation of histamine H3 and H4 receptors. | Acta Pharmacol Sin | 2026 | 40877594 | PubTator, text mining | PubMed |
| The Histamine-Associated Inflammatory Landscape of Endometriosis: Molecular Profiling of HDC, HRH1-HRH4, and Cytokines Across Lesion Subtypes. | Int J Mol Sci | 2025 | 41516088 | PubTator, text mining | PubMed |
| Airway transcriptome networks for ozone and PM2.5 exposure reveal distinct key drivers for children with asthma. | Genome Med | 2025 | 41430723 | PubTator, text mining | PubMed |
| Monocyte inflammation and resilience to Alzheimer's disease: novel genetic risk genes identified by transcriptome-wide association study. | Transl Psychiatry | 2025 | 41253753 | PubTator, text mining | PubMed |
| Blockade of PAR2 Signaling by Punicalagin as a Therapeutic Strategy for Atopic Dermatitis. | Int J Mol Sci | 2025 | 41009488 | PubTator, text mining | PubMed |
Correction to: Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic targets in TNBC and HER2 + subtypes. | Breast Cancer Res Treat | 2025 | 40911221 | PubTator, text mining | PubMed |
| Histamine as a mediator of cross-talk between human lung mast cells and macrophages. | Sci Rep | 2025 | 40885833 | PubTator, text mining | PubMed |
| Targeting Intracellular Pathways in Atopic Dermatitis with Small Molecule Therapeutics. | Curr Issues Mol Biol | 2025 | 40864813 | PubTator, text mining | PubMed |
| The effect of thyroid disorders on the cutaneous manifestations in patients with chronic kidney disease. | Ren Fail | 2025 | 40755254 | PubTator, text mining | PubMed |
| Exploring the therapeutic potential of H1-antihistamines in endometriosis-A gene regulation-based perspective. | Front Med (Lausanne) | 2025 | 40747097 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/59340/papers